Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome

This publication has 11 references indexed in Scilit:

• Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis
  Published by Elsevier ,2000
• Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs
  Fertility and Sterility, 1999
• The role of luteinizing hormone in folliculogenesis and ovulation induction
  Fertility and Sterility, 1999
• A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients
  Human Reproduction, 1998
• Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome
  Fertility and Sterility, 1997
• The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women
  Human Reproduction, 1996
• Aggressive sperm immobilization prior to intracytoplasmic sperm injection with immature spermatozoa improves fertilization and pregnancy rates
  Human Reproduction, 1996
• Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis
  Fertility and Sterility, 1995
• An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos
  Journal of Assisted Reproduction and Genetics, 1989
• Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985